![Supply Chain Resilience Through Geographic Redundancy [Simtra BioPharma Solutions CEO] Podcast Por arte de portada](https://m.media-amazon.com/images/I/51i+tN66feL._SL500_.jpg)
Supply Chain Resilience Through Geographic Redundancy [Simtra BioPharma Solutions CEO]
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Supply Chain Resilience Through Geographic Redundancy [Simtra BioPharma Solutions CEO]
-
Narrado por:
-
De:
“We’re not trying to be everything for everyone. Our specialized focus has been very exciting for me.”
Franco Negron, CEO of Simtra BioPharma Solutions, has transformed a 65-year sterile manufacturing legacy into an independent CDMO since the company’s carve-out from Baxter International (Baxter) in October 2023. Franco has led over $500 million in capital investments to double capacity and create mirrored capabilities across sites in Indiana, US, and Halle/Westfalen, Germany.
Franco brings industry experience from Procter & Gamble, Johnson & Johnson, Novartis, and Patheon, which became part of Thermo Fisher Scientific, where he helped shape integrated CDMO strategies.
In this PharmaSource podcast, recorded at CPHI 2025, Franco explains how Simtra is navigating supply chain challenges, tariff uncertainties, and injectable manufacturing complexity, from GLP-1s to antibody drug conjugates.
Read more.